Codes / ICD10CM / B67.39

B67.39 Echinococcus granulosus infection, other sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Echinococcus granulosus infection, other sites

Summary

Echinococcus granulosus infection, other sites, is a parasitic condition caused by the tapeworm Echinococcus granulosus. It involves the formation of cysts in organs or tissues beyond the liver or lungs, such as the spleen, kidneys, bones, or brain. This zoonotic infection results from ingesting parasite eggs, which develop into cysts in various body sites. The disease may be asymptomatic or cause symptoms depending on cyst location, size, and complications. It is part of cystic echinococcosis, the most common form of echinococcosis.

Causes

The infection is caused by ingesting eggs of Echinococcus granulosus, which are shed in the feces of infected definitive hosts (typically dogs, foxes, or other canids). These eggs contaminate soil, water, or food. Upon ingestion, the eggs hatch in the human intestine, releasing larvae that migrate to organs and develop into cysts. The cysts grow slowly over years, potentially causing tissue damage or complications.

Risk Factors

  • Living in or traveling to regions where the parasite is endemic (e.g., parts of South America, Africa, Asia, or Eastern Europe).
  • Close contact with dogs or other definitive hosts, especially in rural or pastoral settings.
  • Ingesting food or water contaminated with parasite eggs.
  • Occupational exposure, such as farming or animal husbandry.
  • Lack of access to clean water or sanitation in endemic areas.

Symptoms

Symptoms depend on the cyst's location and size. Common manifestations include pain, swelling, or mass effect in the affected area. For example, bone involvement may cause fractures or deformity, while brain cysts can lead to neurological symptoms like headaches, seizures, or focal deficits. Some infections remain asymptomatic until complications arise.

Diagnosis

Diagnosis involves imaging (e.g., ultrasound, CT, or MRI) to detect cysts. Serological tests (e.g., ELISA) may detect antibodies, but false negatives can occur. Biopsy or surgical removal of cysts confirms the diagnosis. Clinical history, including exposure to endemic regions or animals, supports evaluation.

Treatment Options

Treatment depends on cyst location, size, and complications. Options include:

  • Antiparasitic therapy: Albendazole or mebendazole to reduce cyst size and prevent growth.
  • Percutaneous drainage: Aspiration or catheterization to remove cyst contents, often combined with antiparasitics.
  • Surgery: Complete cyst removal (cystectomy) for accessible or complicated cases, minimizing spillage to avoid recurrence.

Prognosis and Follow-Up

Prognosis is generally good with early treatment, but complications (e.g., cyst rupture, infection, or organ damage) can worsen outcomes. Long-term follow-up with imaging and serology is recommended to monitor for recurrence or residual disease. Treatment duration may extend months to years.

Complications

Potential complications include cyst rupture (causing anaphylaxis or dissemination), secondary bacterial infection, organ dysfunction (e.g., liver failure, renal impairment), or neurological deficits if the brain is involved. Rarely, untreated infection can be fatal.

Lifestyle & Prevention

  • Avoid contact with stray dogs or their feces in endemic areas.
  • Wash hands thoroughly after handling animals or soil.
  • Consume only safe, cooked food and clean water when traveling to high-risk regions.
  • Deworm pets regularly and practice good hygiene in pastoral settings.

When to Seek Professional Help

Seek care if you experience unexplained pain, swelling, or mass in any body part, especially after travel to endemic regions. Prompt evaluation is critical if symptoms worsen or involve vital organs (e.g., brain, heart).

Tips for Medical Coders

Code B67.39 is used for Echinococcus granulosus infection in sites other than the liver, lungs, thyroid, or multiple sites. Document the specific affected organ or tissue (e.g., spleen, bone) to support coding accuracy. Ensure clinical correlation with imaging or biopsy results, as asymptomatic cases may still require coding if diagnosed.

Book a walkthrough

B67.39 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.